Effectiveness and Safety of the RIGHTEST Continuous Glucose Monitoring System for Blood Glucose Management in Persons With Diabetes Mellitus
NCT04838392
Autoimmune Diseases, Diabetes Mellitus
Guntersville, Alabama, United States
View Trial DetailsNCT Number: NCT06706609
This study aims to classify adult-onset diabetes patients into distinct data-driven clusters, such as severe insulin-deficient, severe insulin-resistant, mild obesity-related, and mild age-related diabetes, based on clinical and biochemical characteristics. Using a cross-sectional design, data will be collected from individuals attending outpatient diabetes clinics at tertiary care hospitals in Pakistan. The study will analyze the distribution of metabolic and demographic characteristics within each cluster and assess subgroup-specific risks for diabetic complications. Additionally, the relationship between clustering variables and the risk of complications will be evaluated to enhance the understanding of diabetes heterogeneity and its impact on patient outcomes.
Trial opening soon.
Get Notified16 year and older
All sexes
Observational
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: At the time of clinic visit during enrollment
Time frame: At the time of clinic visit during enrollment
Time frame: At the time of clinic visit during enrollment
Time frame: At the time of clinic visit during enrollment
Contact information is provided by the study sponsor or research team.
Dr Jahanzeb Kamal Khan, MBBS, MBA, CRCP, MCPS
CONTACT
Dr Shaheryar Hasan, MBBS, MBA
CONTACT
Getz Pharma
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04838392
Autoimmune Diseases, Diabetes Mellitus
Guntersville, Alabama, United States
View Trial DetailsNCT07011147
Autoimmune Diseases, Diabetes
Aurora, Colorado, United States
View Trial DetailsNCT07386340
Autoimmune Diseases, Diabetes Mellitus
Escondido, California, United States
View Trial DetailsNCT05282680
Autoimmune Diseases, Brain Diseases
Shatin, Hong Kong
View Trial Details